NEW YORK (GenomeWeb News) – DASA Group and Natera have reached a deal to offer Natera's non-invasive prenatal diagnostic test in Brazil, the companies announced on Thursday.
Financial and other terms were not disclosed.
Called Panorama, Natera's test detects trisomy 21, 18, and 13 and monosomy X with a simple blood draw from the mother. Panorama was launched in December.
In June, San Carlos, Calif.-based Natera announced a deal with Unilabs to offer the test in Switzerland and Scandinavia. Natera also has distribution deals with Arup Laboratories, Quest Diagnostics, and Bio-Reference Laboratories.
DASA, based in Sao Paulo, offers diagnostic services in Brazil. Panorama will be offered through the Delboni brands Sergio Franco and Alta, which are part of DASA.